RH&P Global Life Sciences Fund I EUR Dis (LU1178102759)
132.53
+2.19
(+1.68%)
EUR |
Aug 25 2026
LU1178102759 Net Asset Value
Net Asset Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Asset Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 132.53 |
| August 24, 2026 | 130.34 |
| August 21, 2026 | 131.15 |
| August 20, 2026 | 129.89 |
| August 19, 2026 | 132.28 |
| August 18, 2026 | 127.06 |
| August 17, 2026 | 126.52 |
| August 14, 2026 | 124.19 |
| August 13, 2026 | 124.79 |
| August 12, 2026 | 125.89 |
| August 11, 2026 | 126.06 |
| August 10, 2026 | 126.47 |
| August 07, 2026 | 125.33 |
| August 06, 2026 | 121.59 |
| August 05, 2026 | 121.92 |
| August 04, 2026 | 121.41 |
| August 03, 2026 | 119.42 |
| July 31, 2026 | 120.02 |
| July 30, 2026 | 124.01 |
| July 29, 2026 | 123.13 |
| July 28, 2026 | 123.00 |
| July 27, 2026 | 120.70 |
| July 24, 2026 | 121.16 |
| July 23, 2026 | 121.63 |
| July 22, 2026 | 119.98 |
| Date | Value |
|---|---|
| July 21, 2026 | 120.92 |
| July 20, 2026 | 119.16 |
| July 17, 2026 | 121.04 |
| July 16, 2026 | 121.70 |
| July 15, 2026 | 120.74 |
| July 14, 2026 | 119.62 |
| July 13, 2026 | 120.45 |
| July 10, 2026 | 121.47 |
| July 09, 2026 | 124.71 |
| July 08, 2026 | 124.19 |
| July 07, 2026 | 125.51 |
| July 06, 2026 | 124.54 |
| July 03, 2026 | 124.75 |
| July 02, 2026 | 124.77 |
| July 01, 2026 | 121.45 |
| June 30, 2026 | 121.07 |
| June 29, 2026 | 121.02 |
| June 26, 2026 | 120.44 |
| June 25, 2026 | 117.66 |
| June 24, 2026 | 115.92 |
| June 23, 2026 | 113.10 |
| June 19, 2026 | 112.02 |
| June 18, 2026 | 112.02 |
| June 17, 2026 | 111.75 |
| June 16, 2026 | 111.16 |
Net Asset Value (NAV) Definition
Net Asset Value measures the total value of a security based on assets divided by shares outstanding. This metric is calculated by (Total Assets - Total Liabilities) / Shares Outstanding.
Net Asset Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Asset Value Benchmarks
| MEDICAL BioHealth S | 786.53 |
| Selectra Investments J. Lamarck Biotech D | 144.98 |
| Pharus SICAV - Medical Innovation B EUR Acc | 1375.45 |
| Allianz Biotechnologie - R - EUR | 206.69 |
| DWS ESG Biotech TFC | 224.41 |
Net Asset Value Excel Add-In Codes
| Metric Code: net_asset_value |
| Latest Data Point: =YCP("M:LU1178102759", "net_asset_value") |
| Last 5 Data Points: =YCS("M:LU1178102759", "net_asset_value", -4) |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |